Clinical Trial: 400mcg Sublingual Misoprostol as First Line Treatment

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: Introduction of 400mcg Sublingual Misoprostol as First Line Treatment in 11 Health Posts in Three Districts in Senegal

Brief Summary: Women presenting with incomplete abortion and eligible for treatment with misoprostol were offered 400mcg sublingual misoprostol for treatment. Based on existing literature, the study hypothesises that women can successfully be treated with misoprostol alone as first line treatment.